Executive Leadership Team

Jerome Kim, M.D.

Jerome H. Kim, M.D., is the Director General of the International Vaccine Institute (IVI). He served as the Principal Deputy and Chief, Laboratory of Molecular Virology and Pathogenesis at MHRP as well as the Project Manager for the HIV Vaccines and Advanced Concepts Evaluation Project Management Offices, U.S. Army Medical Materiel Development Activity USA. Dr. Kim was a Professor, Division of Infectious Diseases, Department of Medicine, Uniformed Services University of the Health Sciences. From 2004 – 2009 he led the Army’s Phase III HIV vaccine trial (RV144), the first demonstration that an HIV vaccine could protect against infection, as well as subsequent studies that identified laboratory correlates of protection and sequence changes in breakthrough HIV infections after vaccination. He has authored over 200 publications. Dr. Kim graduated from the Yale University School of Medicine in 1984 and completed his training in Internal Medicine and fellowship in Infectious Diseases at Duke University Medical Center. In 2013 he received the John Maher Award for Research Excellence from the Department of Medicine, Uniformed Services University of the Health Sciences.

Julia Lynch, M.D.

Dr. Lynch is Deputy Director General of Development & Delivery. Prior to IVI, she served 29 years in the U.S. Army. Dr. Lynch first served as Director of the Division of Viral Diseases at the Walter Reed Army Institute of Research during which significant studies were conducted for Japanese encephalitis, adenovirus and dengue vaccines. She was appointed Director of the Military Infectious Disease Research Program at Fort Detrick, Maryland, a product development program targeting vaccines against malaria, dengue and enteric pathogens, as well as new anti-parasitic drugs and infectious disease diagnostics for resource limited settings. She later became the Science Director for the Armed Forces Research Institute of Medical Sciences in Bangkok, Thailand, where she was responsible for activities spanning eight countries in South-East Asia that included biosurveillance, basic science, pre-clinical studies and human clinical trials. Dr. Lynch received her M.D. from Columbia University and completed a Pediatric Residency and Infectious Disease fellowship at the Walter Reed Army Medical Center.

In Kyu Yoon, M.D.

In-Kyu Yoon is the Deputy Director General of Science and the Director of the Global Dengue & Aedes-Transmitted Diseases Consortium (GDAC). Dr. Yoon was the former Chief of Virology, Armed Forces Research Institute of Medical Sciences in Bangkok, Thailand. In his previous position, Dr. Yoon investigated arbovirus and respiratory virus infections to include clinical trials of candidate vaccines. He has conducted research on the epidemiology, pathophysiology and immunology of dengue virus and other emerging pathogens, and has authored over 90 publications. Dr. Yoon has provided medical care in a variety of civilian and military healthcare settings internationally, and served as a faculty member of the Uniformed Services University of the Health Sciences, USA. He is a Fellow of the American College of Physicians. Dr. Yoon graduated magna cum laude with a Bachelor of Science degree in Paleobiology from Yale University, and received his Doctorate in Medicine from the New York University School of Medicine. He performed his residency in Internal Medicine and completed a fellowship in Allergy/Immunology at the Walter Reed Army Medical Center, USA.

Philip Driver, C.P.A., A.C.A.

Mr. Philip Driver is the Deputy Director General of Finance & Operations. As a finance professional with extensive global pharmaceuticals experience, Mr. Driver has served in increasingly senior finance positions during a 25 year career with GlaxoSmithKline (GSK). Most recently, he was Senior Vice President Finance and Global Lead Analytics in London, UK. Prior, he held positions as Senior Vice President Finance of Global Consumer Healthcare and spent 6 years as Finance Head of European Pharmaceuticals. He has also been responsible for finance in GSK’s Asia Pacific and Latin American operations, after commencing his pharmaceutical career with GSK in Canada. Mr. Driver was born in England and has lived in England, Canada, U.S., Mexico as well as 5 years in Asia during his career. He holds a C.P.A. from Canada and an A.C.A from U.K.

Kyung-Taik Han, Ph.D.

Dr. Han is the Deputy Director General of IVI’s Government Affairs & Governance Unit. This newly established unit will oversee engagement with the Korean government and other stakeholders in the Republic of Korea, and ensure that governance and internal control are in compliance with donor requirements and international accounting standards. As Deputy Director General, Dr. Han will also serve on IVI’s leadership team. Dr. Han has more than 30 years’ experience as a senior official in the Korean government in areas that include economic policy, budgeting and planning, and trade. Among his positions were Director General of the Technology & Safety Policy Bureau, Ministry of Construction and Transportation; Director General of the Policy Analysis Bureau, National Economic Advisory Council; and Chief Executive Auditor of the Korea Credit Guarantee Fund. He previously worked with IVI as a consultant, providing support and guidance on government issues. He is an Adjunct Professor at the College of Business and Technology of Seoul National University of Science and Technology. Dr. Han has a Ph.D. in economics from the University of Hawaii; Master of Science degree in management science from the Korea Advanced Institute of Science and Technology (KAIST); and Master of Public Administration degree and Bachelor of Arts degree in economics from Seoul National University. He is an Internal Auditor certified by the Institute of Internal Auditors, U.S.A.

Deborah Hong, M.P.A.

Ms. Deborah Hong is Head of IVI’s PR & Communications. Prior to IVI, Ms. Hong managed health education at the Charles B. Wang Community Health Center in New York City, where she managed several health communication projects in collaboration with the New York City Department of Health, New York University Center for the Study of Asian American Health, March of Dimes Foundation, What to Expect Foundation, and Bristol-Myers Squibb.  Ms. Hong worked in China as a consultant in the pharmaceutical and fine chemicals industries. She has a Master in Public Administration in Health Policy & Management from New York University and a Bachelor of Science in Zoology from the University of British Columbia. She is a member of the Asia Pacific Association of Communications Directors.